Improving Titer, Quality and Efficiency of AAV Manufacturing and Production by Optimizing Osmolality
The study presented here, undertaken by Cell and Gene Therapy Catapult, provides preliminary evidence for impact on overall yield, and quality of the adeno-associated virus 1 (AAV) due to a timed osmolality shift with and without a feeding step.
Osmolality, a measure of solute concentration, can have many applications throughout the entirety of the cell and gene therapy process. There is now clear evidence to show how the manipulation of this critical process parameter can improve overall outcomes.